Global Cell Line Development Market Report By Product (Reagents & Media, Equipment, And Accessories & Consumables), Source (Mammalian And Non-Mammalian), By Cell Line (Recombinant, Hybridomas, Hybridomas, And Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, And Research) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2018-2025
ID:VMR11210338
January 2019
Report Formats:

As per this study the Global Cell Line Development Market was valued USD XXX MN (by revenue) in 2018 and is anticipated to reach USD XXX MN by 2025 with a CAGR of X.X%.

Cell line development is a process which helps to produce therapeutic drugs through genetic manipulation of organism or cell. It improves the high yield of pharmaceutical products by reducing production cost. Cell line development is also used to produced vaccines, cell culture, and drug discovery. They have application across biopharmaceutical, Research center, and biotechnology sector.
 
Market Dynamics
 
Expanding biopharmaceutical industry is expected to drive the demand for cell line development procedure. Rising demand for monoclonal antibodies, cancer therapeutics drugs, and the availability of advanced technologies to produce novel cell lines are again expected to augment market growth. Also, the rising prevalence of chronic diseases needs effective treatment solutions thereby fueling the demand to produce vaccines, biosimilars, therapeutic proteins, and novel drugs over the forecast timeline. Moreover, growing adoption of regenerative medicine, increasing healthcare expenditure and the rise in investments in the biotechnology sector are also some of the major factors contributing to the industry growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of cell line development.
 
Market Segmentation
 
The broad cell line development market has been sub-grouped into product, source, cell line, and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product

  • Reagents & Media
  • Equipment
  • Accessories & Consumables
 
By Source
  • Mammalian
  • Non-Mammalian
 
By Cell Line
  • Recombinant
  • Hybridomas
  • Continuous Cell Line
  • Primary Cell Line
 
By Application
  • Bioproduction
  • Drug Discovery
  • Toxicity Testing
  • Tissue Engineering
  • Research
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for cell line development in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Cell Line Development Market By Revenue (USD MN)
 
Europe Cell Line Development Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the cell line development market include American Type Culture Collection, Cytovance Biologics, GE Healthcare, Lonza Group AG, Sartorius Stedim Biotech GmbHCorning Inc., Selexis SA, Sigma-Aldrich Corporation (Merck), Thermo Fisher Scientific Inc., and WuXi AppTec. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Cell Line Development
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Cell Line Development Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. CELL LINE DEVELOPMENT MARKET ANALYSIS BY PRODUCT
  • Market In Reagents & Media
  • Market In Equipment
  • Market In Accessories & Consumables
 
5. CELL LINE DEVELOPMENT MARKET ANALYSIS BY SOURCE
  • Market In Mammalian
  • Market In Non-Mammalian
 
6. CELL LINE DEVELOPMENT MARKET ANALYSIS BY CELL LINE
  • Market In Recombinant
  • Market In Hybridomas
  • Market In Continuous Cell Line
  • Market In Primary Cell Line
 
7. CELL LINE DEVELOPMENT MARKET ANALYSIS BY APPLICATION
  • Market In Bioproduction
  • Market In Drug Discovery
  • Market In Toxicity Testing
  • Market In Tissue Engineering
  • Market In Research
 
8. CELL LINE DEVELOPMENT MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
9. COMPETITIVE LANDSCAPE OF THE CELL LINE DEVELOPMENT COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
10. COMPANY PROFILES OF THE CELL LINE DEVELOPMENT INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • American Type Culture Collection
  • Cytovance Biologics
  • GE Healthcare
  • Lonza Group AG
  • Sartorius Stedim Biotech GmbH
  • Corning Inc.
  • Selexis SA
  • Sigma-Aldrich Corporation (Merck)
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
  • Others
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Cell line development
Table 2.  Global Cell line development Market By Product
Table 3.  Global Cell line development Market By Source
Table 4.  Global Cell line development Market By Cell Line
Table 5.  Global Cell line development Market By Application
Table 6.  Global Cell line development Market By Geography
Table 7.  North America Cell line development Market
Table 8.  Europe Cell line development Market
Table 9.  Asia Pacific Cell line development Market
Table 10. Latin America Cell line development Market
Table 11. Middle East And Africa Cell line development Market 
Table 12. Partnership/Collaboration/Agreements
Table 13. Mergers And Acquisitions
Table 14. New Product Development
Table 15. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Cell Line Development Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Cell Line Development
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Cell Line Development Market By Product
Fig. 8.     Global Cell Line Development Market By Source
Fig. 9.     Global Cell Line Development Market By Cell Line
Fig. 10.   Global Cell Line Development Market By Application
Fig. 11.   Global Cell Line Development Market By Geography
Fig. 12.   North America Cell Line Development Market
Fig. 13.   Europe Cell Line Development Market
Fig. 14.   Asia Pacific Cell Line Development Market
Fig. 15.   Latin America Cell Line Development Market
Fig. 16.   Middle East And Africa Cell Line Development Market
Fig. 17.   Market Share Of Cell Line Development Companies
Fig. 18.   Recent Developments In Cell Line Development Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials